Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ:ARCT)

6.660 -0.210 (-3.06%)
Streaming Delayed Price Updated: 2:19 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Arcturus Therapeutics Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
These Are the Only 3 Stocks That Cathie Wood Bought Last Week ↗
The growing investing icon was skimpy on her purchases last week, making the names she did buy that much more interesting. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Arcturus (ARCT) Q4 2025 Earnings Call Transcript ↗
Arcturus (ARCT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Lawsuit
Arcturus Therapeutics (NASDAQ:ARCT) Stock Falls After Q4 2025 Revenue Miss ↗
Via Chartmill
News headline image
Arcturus Therapeutics (NASDAQ:ARCT) Reports Mixed Q3 2025 Results, Extends Cash Runway to 2028 ↗
Arcturus Q3 2025 results show a revenue miss but a smaller-than-expected loss. The company advances its CF and OTC programs, with cash extending into 2028. 
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
 
Via Benzinga
News headline image
Preview: Arcturus Therapeutics's Earnings ↗
 
Via Benzinga
News headline image
This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Cathie Wood Goes Shopping: 3 Stocks She Just Bought ↗
The growth-focused money manager only bought three stocks on Wednesday. Let's check out that shopping list. 
Via The Motley Fool
Topics ETFs
News headline image
Where Arcturus Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Arcturus' Investigational Inhaled Therapy Lacks Meaningful Lung Function Improvement, Analyst Notes Mixed Picture ↗
Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but no initial FEV₁ improvement. 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off? ↗
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing. 
Via Stocktwits
News headline image
Arcturus Crashes 55% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug ↗
The company is working on a treatment for cystic fibrosis using messenger RNA, or mRNA, technology. 
Via Investor's Business Daily
News headline image
Wednesday's pre-market session: top gainers and losers ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA), 
Via Benzinga
Topics Artificial Intelligence
News headline image
Forecasting The Future: 5 Analyst Projections For Arcturus Therapeutics ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers in Tuesday's session ↗
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
Arcturus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.